See also this year's filing and all EDGAR filings for this company.
PDF Report 0001159019_2013_Tribute_Pharmaceuticals_Canada_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001159019, Tribute Pharmaceuticals Canada Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,885,636 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 14,482,256 |
| 2 | PropertyPlantAndEquipmentNet | 1,159,375 |
| 3 | remainder_Assets | 301,265 |
| 4 | LiabilitiesCurrent | 6,761,504 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,332,904 |
| 7 | CostOfGoodsAndServicesSold | 1,220,716 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,870,609 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 6,672,171 |
| 11 | remainder_Revenues | 12,342,783 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 1,071,747 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,828,532 |
| 1 | Liabilities | 9,094,408 |
| 2 | Expenses | 16,763,496 |
| 3 | Revenues | 12,342,783 |
| 4 | StockholdersEquity | 11,734,124 |
| 5 | NetIncome | -4,420,713 |
| 6 | ComprehensiveNetIncome | -3,884,840 |
| 7 | BaseVar | 30,050,483 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.45 |
| 9 | EconomicCapitalRatio | 2.64 |
Edgar->Model Mapping
Feature Distribution
Change over Time
